Comet Therapeutics is a biotechnology company developing drugs to address previously untreatable Inherited Metabolic Diseases (IMDs) using its proprietary CoMET platform, which aims to restore cellular metabolism by providing a stabilized Coenzyme A precursor
Comet Therapeutics is a biotechnology company developing drugs to address previously untreatable Inherited Metabolic Diseases (IMDs) using its proprietary CoMET platform, which aims to restore cellular metabolism by providing a stabilized Coenzyme A precursor.